Kramer, Hester
Bicer, Ceyhun
Otoul, Christian
Rospo, Chiara
Macpherson, Merran
Watling, Mark
Bani, Massimo
Sciberras, David
Chanteux, Hugues http://orcid.org/0000-0002-2222-9813
Article History
Received: 23 May 2023
Accepted: 3 October 2023
First Online: 16 November 2023
Declarations
:
: The clinical studies were conducted in compliance with the Declaration of Helsinki and with all International Conference on Harmonization Good Clinical Practice guidelines. In addition, all local regulatory requirements were followed, in particular, those affording greater protection to the safety of trial participants. The final protocol, amendments, and informed consent documentation were reviewed and approved by Institutional Review Boards and/or Independent Ethics Committees at each participating center. A signed and dated informed consent was required from each subject before any screening procedures were conducted.
: Hugues Chanteux, Merran MacPherson, Hester Kramer, and Chiara Rospo are employees of UCB Pharma and receive stock/stock options from their employment. Massimo Bani was an employee of UCB Pharma at the time the studies were conducted and is now an employee of Bergmapharm Consulting SRL, Brescia, Italy. Christian Otoul, David Sciberras, and Mark Watling were employees of UCB Pharma at the time the studies were conducted. Ceyhun Bicer is consultant contracted by UCB.